# Midterm outcomes in patients with intermediate‐sized hepatocellular carcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/midterm-outcomes-in-patients-with-intermediate-sized-hepatocellular-carcinoma/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Manabu Morimoto,Kazushi Numata,Masaaki Kondou,Akito Nozaki,Satoshi Morita,Katsuaki Tanaka |
| Citations | 330 |
| DOI | 10.1002/cncr.25314 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2054903266 |
| PMID | 20672352 |
| Type | article |
| Year | 2010 |

## Paper authors

- [Manabu Morimoto](https://scholariq.org/researchers/manabu-morimoto/)

## Paper journal

- [Cancer](https://scholariq.org/journals/cancer/)

## Paper primary topic

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

## Paper topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.